Figure 5 compares mRNA expression levels of TMEM106B between cognitively unimpaired individuals (CU) and individuals with progressive supranuclear palsy (PSP), pathological aging (PA) and Alzheimer’s disease (AD) from the Mayo clinic cohort. The gene discussed is TMEM106B; the disease is Alzheimer disease.